These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 34856584)

  • 21. Predictors and Outcomes of Upstaging in Rectal Cancer Patients Who Did Not Receive Preoperative Therapy.
    Antunez AG; Kanters AE; Regenbogen SE
    Dis Colon Rectum; 2023 Jan; 66(1):59-66. PubMed ID: 35905174
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Delayed TME Surgery in a Watch-and-Wait Strategy After Neoadjuvant Chemoradiotherapy for Rectal Cancer: An Analysis of Hospital Costs and Surgical and Oncological Outcomes.
    Meyer VM; Meuzelaar RR; Schoenaker IJH; de Groot JB; Reerink O; de Vos Tot Nederveen Cappel WH; Beets GL; van Westreenen HL
    Dis Colon Rectum; 2023 May; 66(5):671-680. PubMed ID: 34856587
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transanal Endoscopic Microsurgery Versus Total Mesorectal Excision in ypT0-1 Rectal Cancer After Preoperative Radiochemotherapy: Postoperative Morbidity, Functional Results, and Long-term Oncologic Outcome.
    Rizzo G; Pafundi DP; Sionne F; Pietricola G; D'Agostino L; Gambacorta MA; Valentini V; Coco C
    Dis Colon Rectum; 2022 Nov; 65(11):1306-1315. PubMed ID: 35067503
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of Tumor Location on Outcome After Laparoscopic Low Rectal Cancer Surgery: A Propensity Score Matching Analysis.
    Wu Q; Jin Z; Zhang X; Deng X; Peng Y; Wang Z
    Dis Colon Rectum; 2022 May; 65(5):672-682. PubMed ID: 35394940
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rectal Cancer: Clinical and Molecular Predictors of a Complete Response to Total Neoadjuvant Therapy.
    Chapman BC; Lai SH; Friedrich T; Lieu CH; Moskalenko M; Olsen JR; Herter W; Birnbaum EH; McCarter MD; Vogel JD
    Dis Colon Rectum; 2023 Apr; 66(4):521-530. PubMed ID: 34984995
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Clinicopathological Feature-Based Nomogram for Predicting the Likelihood of D3 Lymph Node Metastasis in Right-Sided Colon Cancer Patients.
    Long C; Feng M; Wang S; Ji H; Li Z; Zheng J; Jiang W; Yan J
    Dis Colon Rectum; 2023 Jan; 66(1):75-86. PubMed ID: 34897214
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transanal Total Mesorectal Excision Versus Anterior Total Mesorectal Excision for Rectal Cancer: A Propensity Score Matched, Population-Based Study in Catalonia, Spain.
    Manchon-Walsh P; de Lacy FB; Pera M; Espin-Basany E; Targarona EM; Biondo S; Aliste Sanchez L; Pallarès N; Tebé C; Pata F; Lacy AM; Guarga A; Borràs JM
    Dis Colon Rectum; 2022 Feb; 65(2):207-217. PubMed ID: 34636779
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High Risk of Low Anterior Resection Syndrome in Long-term Follow-up After Anastomotic Leakage in Anterior Resection for Rectal Cancer.
    Jutesten H; Buchwald PL; Angenete E; Rutegård M; Lydrup ML
    Dis Colon Rectum; 2022 Oct; 65(10):1264-1273. PubMed ID: 35482994
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Uptake of Total Mesorectal Excision and Total Mesorectal Excision Grading for Rectal Cancer: A Statewide Study.
    Kanters AE; Cleary RK; Obi SH; Asgeirsson T; Evilsizer SK; Fasbinder LG; Campbell DA; Hendren SK
    Dis Colon Rectum; 2020 Jan; 63(1):53-59. PubMed ID: 31633602
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A US Rectal Cancer Consortium Study of Inferior Mesenteric Artery Versus Superior Rectal Artery Ligation: How High Do We Need to Go?
    Turgeon MK; Gamboa AC; Regenbogen SE; Holder-Murray J; Abdel-Misih SRZ; Hawkins AT; Silviera ML; Maithel SK; Balch GC
    Dis Colon Rectum; 2021 Oct; 64(10):1198-1211. PubMed ID: 34192711
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lack of Complete Pretreatment Staging Is Associated With Omission of Neoadjuvant Therapy for Rectal Cancer: A Statewide Study.
    Tang D; Rivard SJ; Weng W; Ramm CA; Cleary RK; Hendren S
    Dis Colon Rectum; 2023 May; 66(5):662-670. PubMed ID: 35195556
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early Experience With Transanal Total Mesorectal Excision Compared With Laparoscopic Total Mesorectal Excision for Rectal Cancer: A Propensity Score-Matched Analysis.
    Alhanafy MK; Park SS; Park SC; Park B; Kim MJ; Sohn DK; Chang HJ; Oh JH
    Dis Colon Rectum; 2020 Nov; 63(11):1500-1510. PubMed ID: 33044291
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adjuvant Chemotherapy Does Not Improve Recurrence-Free Survival in Patients With Stage 2 or Stage 3 Rectal Cancer After Neoadjuvant Chemoradiotherapy and Total Mesorectal Excision.
    Voss RK; Lin JC; Roper MT; Al-Temimi MH; Ruan JH; Tseng WH; Tam M; Sherman MJ; Klaristenfeld DD; Tomassi MJ
    Dis Colon Rectum; 2020 Apr; 63(4):427-440. PubMed ID: 31996583
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low Anterior Resection Syndrome After Transanal Total Mesorectal Excision: A Comparison With the Conventional Top-to-Bottom Approach.
    Foo CC; Kin Ng K; Tsang JS; Siu-Hung Lo O; Wei R; Yip J; Lun Law W
    Dis Colon Rectum; 2020 Apr; 63(4):497-503. PubMed ID: 32015290
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Patient Survival With ypT0N+ Following Neoadjuvant Therapy in Rectal Cancer.
    Elshami M; Goldstone RN; Blaszkowsky LS; Cusack JC; Hong TS; Wo JY; Qadan M
    Dis Colon Rectum; 2022 Oct; 65(10):1224-1231. PubMed ID: 35714358
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Functional Outcomes and Quality of Life After Transanal Total Mesorectal Excision for Rectal Cancer: A Prospective Observational Study.
    de Lacy FB; Turrado-Rodriguez V; Torroella A; van Laarhoven J; Otero-Piñeiro A; Almenara R; Lacima G; Castells A; Lacy AM
    Dis Colon Rectum; 2022 Jan; 65(1):46-54. PubMed ID: 34596984
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Circumferential Resection Margin Status as a Predictive Factor for Recurrence in Preoperative MRI for Advanced Lower Rectal Cancer Without Preoperative Therapy.
    Mazaki J; Tsukamoto S; Miyake M; Moritani K; Sakamoto R; Shida D; Kanemitsu Y
    Dis Colon Rectum; 2021 Jan; 64(1):71-80. PubMed ID: 33306533
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Prospective Multicenter Phase II Study on the Feasibility and Efficacy of S-1 and Oxaliplatin Neoadjuvant Chemotherapy for Locally Advanced Rectal Cancer.
    Sakamoto Y; Morohashi H; Miura T; Tsutsumi S; Takahashi S; Hirama K; Wakiya T; Hakamada K
    Dis Colon Rectum; 2022 May; 65(5):663-671. PubMed ID: 33833145
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neoadjuvant Therapy in Stage II/III Rectal Cancer: A Retrospective Study in a Disparate Population and the Effect on Survival.
    Gan T; Chen Q; Huerta CT; Huang B; Evers BM; Patel JA
    Dis Colon Rectum; 2021 Oct; 64(10):1212-1221. PubMed ID: 34516443
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Surgical Approach to Transverse Colon Cancer: Analysis of Current Practice and Oncological Outcomes Using the National Cancer Database.
    Crippa J; Grass F; Achilli P; Behm KT; Mathis KL; Day CN; Harmsen WS; Mari GM; Larson DW
    Dis Colon Rectum; 2021 Mar; 64(3):284-292. PubMed ID: 33555708
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.